Showing results (1-10 of 1,072) with videos related to
Sort By:
Pageof 108
Journal of the American College of Cardiology|November 13, 2010
Antithrombotic therapy in the elderlyDavide Capodanno, Dominick J AngiolilloEuropean Heart Journal|June 22, 2023
Personalised antiplatelet therapies for coronary artery disease: what the future holdsDavide Capodanno, Dominick J AngiolilloThrombosis and Haemostasis|July 29, 2010
Impact of race and gender on antithrombotic therapyDavide Capodanno, Dominick J AngiolilloEuropean Heart Journal. Cardiovascular Pharmacotherapy|August 10, 2021
Oral antithrombotic therapy for the prevention of recurrent cerebrovascular eventsDavide Capodanno, Dominick J AngiolilloCurrent Treatment Options in Cardiovascular Medicine|October 22, 2011
Antithrombotic pharmacotherapy in the elderly: general issues and clinical conundrumsDavide Capodanno, Dominick J AngiolilloExpert Review of Cardiovascular Therapy|March 9, 2016
Reviewing the controversy surrounding pre-treatment with P2Y12 inhibitors in acute coronary syndrome patientsDavide Capodanno, Dominick J AngiolilloJACC. Cardiovascular Interventions|March 11, 2017
Antiplatelet Therapy After Implantation of Bioresorbable Vascular Scaffolds: A Review of the Published Data, Practical Recommendations, and Future DirectionsDavide Capodanno, Dominick J AngiolilloJACC. Cardiovascular Interventions|January 4, 2023
Timing, Selection, Modulation, and Duration of P2Y<sub>12</sub> Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCIDavide Capodanno, Dominick J AngiolilloThrombosis and Haemostasis|July 24, 2015
Management of adjunctive antithrombotic therapy in STEMI patients treated with fibrinolysis undergoing rescue or delayed PCIDavide Capodanno, Dominick J AngiolilloInterventional Cardiology Clinics|November 26, 2016
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs?Davide Capodanno, Dominick J AngiolilloPageof 108